Liquid biopsy using microRNAs for early detection of liver fibrosis progression and hepatocellular carcinoma

Liquid biopsy using microRNAs for early detection of liver fibrosis progression and hepatocellular carcinoma - Investigation of microRNAs for early detection of liver fibrosis progression and hepatocellular carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049394

Enrollment

160

Registered

2022-11-01

Start date

2021-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with and without hepatocellular carcinoma who are being treated for liver disease

Exclusion criteria

Exclusion criteria: Those who the doctor has determined are not suitable for research

Design outcomes

Primary

Measure	Time frame
Blood levels of microRNAs	—

Secondary

Measure	Time frame
Blood levels of microRNAs target mRNAs and gene products	—

Countries

Japan

Contacts

Public ContactMaiko Machida

Hokkaido University of Science Pharmacotherapy

machida-m@hus.ac.jp011-676-8652

Outcome results